The product will be manufactured at Granules manufacturing facility in Chantilly, Virginia, and is expected to be launched shortly, according to a company statement shared with stock exchanges.
According to the statement, both firms would collaborate for green molecule solutions and its wider applications in pharmaceuticals to build a leadership position. Granules also said it would develop a facility at Kakinada in Andhra Pradesh with an estimated cost of Rs 2,000 crore over five
Hyderabad (Telangana) [India], July 21 (ANI): The drug maker Granules India on Wednesday announced that its US-based subsidiary cleared a pre-approval inspection (PAI) audit by the US drug regulator.
Hyderabad (Telangana) [India], Jan 21 (ANI): Granules India Ltd said on Tuesday reported a net profit of Rs 64 crore in the quarter ending December (Q3 FY20), rising over 10.3 per cent from Rs 58 crore in Q3 FY19.
Hyderabad (Telangana) [India], Oct 14 (ANI): Granules India Ltd said on Monday it will divest its entire equity shareholding in its Chinese joint venture Granules Biocause Pharmaceuticals.
Hyderabad (Telangana) [India], Aug 29 (ANI): Pharmaceutical manufacturing firm Granules India said on Thursday it will divest its entire equity shareholding in Granules OmniChem (GOC) by selling its stake to the joint venture partner.
Hyderabad (Telangana) [India], Mar 8 (ANI): Pharmaceutical manufacturing company Granules India said on Friday that its promoters sold 50 lakh shares to a group of reputed investors in a block deal on the stock exchanges to mobilise about Rs 50 crore.